PillRx only · Tablet · Oral
Entecavir
Entecavir
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.259
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
6
Active US suppliers
74%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
25K
Rx · 2026 Q1
990K
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Camber Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 6 | SUPPLYING |
| Epic Pharma, LLC | unknown | 2 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 1 | SUPPLYING |
| American Health Packaging | unknown | 1 | SUPPLYING |
| Carlsbad Technology, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 20, 2017RECALLRecall (Class II): Entecavir Tablets 0.5 mg, 30 tablets per container, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway…
Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point. — Recalling firm: Hetero USA Inc — NJ